Suisun City, CA, United States of America

Richard D Carpenter


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Overview of Inventor Richard D. Carpenter

Introduction

Richard D. Carpenter, based in Suisun City, California, is an accomplished inventor known for his innovative contributions to the field of medical science. With a focus on integrin imaging and therapy, he has developed a patented technology that holds the potential for improving treatments for various diseases.

Latest Patents

Richard D. Carpenter holds a patent for "Heterocyclic ligands for integrin imaging and therapy." This invention centers on αβ integrin ligands that exhibit high binding affinity, specificity, and stability. The ligands consist of a peptide with n independently selected amino acids, where at least one is either an unnatural amino acid or a D-amino acid. The integer n ranges from 3 to 20. The patent outlines methods for administering these ligands to treat cancer, inflammatory diseases, and autoimmune diseases, as well as techniques for imaging a tumor, organ, or tissue in a subject.

Career Highlights

Richard is affiliated with the University of California, a prestigious institution that contributes significantly to research and innovation. His work focuses on the development of ligand technologies that can advance therapeutic approaches in medical treatment.

Collaborations

Throughout his career, Richard has collaborated with notable colleagues, including Mirela Andrei and Ruiwu Liu. These collaborations reflect a commitment to teamwork and a shared vision of advancing medical research and therapies.

Conclusion

In summary, Richard D. Carpenter’s innovative work on integrin ligands highlights his role as a prominent inventor in the medical field. His contributions may pave the way for new treatments and diagnostic methods, showcasing the importance of research and collaboration in advancing healthcare technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…